MYO Myomo Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MYO

Price (delayed)

$3.93

Market cap

$111.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.28

Enterprise value

$105.68M

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the ...

Highlights
The EPS has soared by 82% YoY and by 43% QoQ
The company's gross profit rose by 29% YoY and by 3.8% QoQ
MYO's equity is up by 41% year-on-year but it is down by 18% since the previous quarter
Myomo's net income has increased by 24% YoY but it has decreased by 3.7% from the previous quarter
The quick ratio has contracted by 13% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://myomo.com
Peers: ORGS PDCO

Key stats

What are the main financial stats of MYO
Market
Shares outstanding
28.49M
Market cap
$111.95M
Enterprise value
$105.68M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.59
Price to sales (P/S)
6.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.49
Earnings
Revenue
$19.24M
EBIT
-$7.99M
EBITDA
-$7.47M
Free cash flow
-$6.32M
Per share
EPS
-$0.28
Free cash flow per share
-$0.21
Book value per share
$0.34
Revenue per share
$0.65
TBVPS
$0.49
Balance sheet
Total assets
$14.58M
Total liabilities
$5.59M
Debt
$601,303
Equity
$8.99M
Working capital
$8.17M
Liquidity
Debt to equity
0.07
Current ratio
2.49
Quick ratio
2.05
Net debt/EBITDA
0.84
Margins
EBITDA margin
-38.8%
Gross margin
68.5%
Net margin
-42.3%
Operating margin
-42.8%
Efficiency
Return on assets
-55.5%
Return on equity
-84.7%
Return on invested capital
-262.7%
Return on capital employed
-87.8%
Return on sales
-41.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MYO stock price

How has the Myomo stock price performed over time
Intraday
0.26%
1 week
14.58%
1 month
32.32%
1 year
672.1%
YTD
-21.56%
QTD
20.18%

Financial performance

How have Myomo's revenue and profit performed over time
Revenue
$19.24M
Gross profit
$13.18M
Operating income
-$8.23M
Net income
-$8.15M
Gross margin
68.5%
Net margin
-42.3%
The company's net margin rose by 39% YoY
The operating margin has grown by 38% YoY
The company's gross profit rose by 29% YoY and by 3.8% QoQ
Myomo's net income has increased by 24% YoY but it has decreased by 3.7% from the previous quarter

Growth

What is Myomo's growth rate over time

Valuation

What is Myomo stock price valuation
P/E
N/A
P/B
11.59
P/S
6.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.49
The EPS has soared by 82% YoY and by 43% QoQ
The price to book (P/B) is 136% more than the last 4 quarters average of 4.9
MYO's equity is up by 41% year-on-year but it is down by 18% since the previous quarter
The stock's P/S is 107% above its 5-year quarterly average of 2.9 and 100% above its last 4 quarters average of 3.0
The revenue has increased by 24% year-on-year and by 3.9% since the previous quarter

Efficiency

How efficient is Myomo business performance
Myomo's return on invested capital has surged by 66% YoY and by 6% QoQ
The ROS rose by 39% YoY
The return on assets has grown by 29% year-on-year and by 4.1% since the previous quarter
MYO's ROE is up by 26% year-on-year and by 3.4% since the previous quarter

Dividends

What is MYO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYO.

Financial health

How did Myomo financials performed over time
Myomo's total assets is 161% higher than its total liabilities
The total liabilities has grown by 47% YoY but it has contracted by 7% from the previous quarter
Myomo's total assets has increased by 43% YoY but it has decreased by 14% QoQ
The company's debt is 93% lower than its equity
MYO's equity is up by 41% year-on-year but it is down by 18% since the previous quarter
The debt to equity has decreased by 22% YoY but it has increased by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.